Japan’s Backing of Virus Drug Premature, Says Trial’s Lead Researcher
5 years ago 1 min read
The lead researcher on a trial of the Japanese antiviral Avigan to treat Covid-19 said it’s too early to make a call on whether the drug works or not, and patients are still being enrolled.
More Stories
LGBTQ-inclusive books are hard to find. So these groups started sending them to schools.
At least six arrested as ‘Stop the Steal’ protesters and counter-protesters clash in Washington, DC
Two LA County sheriff’s deputies involved in the fatal shooting of Andres Guardado relieved of duties following unrelated investigation